These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16842268)

  • 21. Live vaccines against bovine babesiosis.
    de Waal DT; Combrink MP
    Vet Parasitol; 2006 May; 138(1-2):88-96. PubMed ID: 16504404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine babesiosis: failure to induce interferon gamma production in response to Babesia bovis antigens in cattle.
    Orinda GO; Gale KR; Wright IG; Parrodi F
    Int J Parasitol; 1992 May; 22(3):395-8. PubMed ID: 1639576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunisation of cattle against Babesia bovis combining a multi-epitope modified vaccinia Ankara virus and a recombinant protein induce strong Th1 cell responses but fails to trigger neutralising antibodies required for protection.
    Jaramillo Ortiz JM; Paoletta MS; Gravisaco MJ; López Arias LS; Montenegro VN; de la Fournière SAM; Valenzano MN; Guillemi EC; Valentini B; Echaide I; Farber MD; Wilkowsky SE
    Ticks Tick Borne Dis; 2019 Oct; 10(6):101270. PubMed ID: 31445874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination against bovine babesiosis.
    De Vos AJ; Bock RE
    Ann N Y Acad Sci; 2000; 916():540-5. PubMed ID: 11193669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking Babesia bovis vaccine reactions of dairy cattle in milk.
    Combrink MP; Carr G; Mans BJ; Marais F
    Onderstepoort J Vet Res; 2012 Dec; 79(1):E1-4. PubMed ID: 23327323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a monoclonal antibody against Babesia bovis merozoite surface antigen-2c for the development of a competitive ELISA test.
    Dominguez M; Zabal O; Wilkowsky S; Echaide I; Torioni de Echaide S; Asenzo G; Rodríguez A; Zamorano P; Farber M; Suarez C; Florin-Christensen M
    Ann N Y Acad Sci; 2004 Oct; 1026():165-70. PubMed ID: 15604488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of a recombinant Babesia vaccine.
    Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA
    Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a rapid immunochromatographic test for simultaneous serodiagnosis of bovine babesioses caused by Babesia bovis and Babesia bigemina.
    Kim CM; Blanco LB; Alhassan A; Iseki H; Yokoyama N; Xuan X; Igarashi I
    Am J Trop Med Hyg; 2008 Jan; 78(1):117-21. PubMed ID: 18187794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel 20-kilodalton protein conserved in Babesia bovis and B. bigemina stimulates memory CD4(+) T lymphocyte responses in B. bovis-immune cattle.
    Brown WC; Ruef BJ; Norimine J; Kegerreis KA; Suarez CE; Conley PG; Stich RW; Carson KH; Rice-Ficht AC
    Mol Biochem Parasitol; 2001 Nov; 118(1):97-109. PubMed ID: 11704278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against canine babesiosis.
    Schetters T
    Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones.
    Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC
    Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Babesia bovis and B. bigemina: Persistence of infection in friesian cows following vaccination with live antibabesial vaccines.
    Pipano E; Shkap V; Kriegel Y; Leibovitz B; Savitsky I; Fish L
    Vet J; 2002 Jul; 164(1):64-8. PubMed ID: 12359486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conserved motif in the immune-subdominant RAP-1 related antigen of
    Rojas MJ; Bastos RG; Navas J; Laughery JM; Lacy PA; Suarez CE
    Front Immunol; 2024; 15():1380660. PubMed ID: 38720894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Babesia bovis live attenuated vaccine.
    Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
    Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity.
    Carcy B; Précigout E; Schetters T; Gorenflot A
    Vet Parasitol; 2006 May; 138(1-2):33-49. PubMed ID: 16551492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of Bos taurus steers with Babesia bovis recombinant antigens MSA-1, MSA-2c and 12D3.
    Antonio Alvarez J; Lopez U; Rojas C; Borgonio VM; Sanchez V; Castañeda R; Vargas P; Figueroa JV
    Transbound Emerg Dis; 2010 Apr; 57(1-2):87-90. PubMed ID: 20537116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Babesia bovis 6cys A and 6cys B as components of transmission blocking vaccines for babesiosis.
    Alzan HF; Bastos RG; Ueti MW; Laughery JM; Rathinasamy VA; Cooke BM; Suarez CE
    Parasit Vectors; 2021 Apr; 14(1):210. PubMed ID: 33879245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.